Cancer Clinical Trials Results
Prospective Multi-Center Cohort for the Evaluation of Biomarkers Predicting Risk of Complications and Mortality Following Allogeneic HCT
||Main Campus|| || ||Blood & Marrow Transplant (BMT)
A Randomized, Multi-Center, Phase III Study of Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia and A Multi-Center, Phase III, Randomized Trial of Reduced Intensity Conditioning (RIC) and Transplantation of Double Unrelated Umbilical Cord Blood (dUCB) versus HLA-Haploidentical Related Bone Marrow for Patients with Hematologic Malignancies
||Main Campus|| ||Phase 3||Blood & Marrow Transplant (BMT), Hematologic Malignancy
A Study of Low-dose Lenalidomide after Non-myeloablative Allogeneic Stem
||Main Campus|| || ||Blood & Marrow Transplant (BMT), Multiple Myeloma
(Adult/Pediatric) KIR Genotyping for Unrelated Donor (URD) Selection Prior to Hematopoietic Cell Transplantation (HCT) for AML: Selecting a Favorable KIR Donor
||Main Campus|| || ||Blood & Marrow Transplant (BMT), Leukemia, Acute Myeloid (AML)
(Adult/Pediatric) A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) for transplantation in pediatric and adult patients with hematologic malignancies and other indications
||Main Campus|| || ||Blood & Marrow Transplant (BMT), Hematologic Malignancy
(Pediatric) Defibrotide for patients with hepatic veno-occlusive disease (VOD): A treatment IND study (Under CFR 312.34)
||Main Campus||Stage 1|| ||Blood & Marrow Transplant (BMT), Hepatic Veno-Occlusive Disease (VOD)
Cancer Answers & Appointments
Speak with a cancer nurse specialist for appointment assistance and for answers to your questions about cancer locally at 216.444.7923 or toll-free 1.866.223.8100.
Monday through Friday from 8 a.m. – 4:30 p.m. (ET).
Resources for medical professionals
- Outpatient appointment referrals: 216.444.7923 or 866.223.8100
- Inpatient hospital transfers: 800.553.5056
- Referring Physician Concierge: 216.444.6196 or 216.312.4910.
Search available cancer clinical trials by disease, hospital, phase or number.